EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57

Abstract

STABILITY OF CO-AMOXICLAV RECONSTITUTED INJECTABLE SOLUTION

Abubakr O. Nur*, Alharith A. A. Hassan, Elrasheed A. Gadkariem, Zuhair Osman, Gamal K. M. Ali

ABSTRACT

Background: The use of co-amoxiclav injectable form among neonates and infants necessitates the usage of a part of the reconstituted drug solution or suspension, based on the relative low weights of this group of patients, with the remaining part of the reconstituted form being discarded and not used for subsequent doses due to unreliability in dosage form stability. This practice increases the cost of the treatment. Objective: This study aims at evaluation of the stability of reconstituted co-amoxiclav injectable solutions in order to use it in the most cost-effective manner. Methods: Physical, chemical and microbiological stability of reconstituted co-amoxiclav injectable solutions were evaluated at 4 different storage conditions which assembled by iterating each of temperature and lighting condition at two possible levels. Responses measured were degradation rate, colour and pH changes, shelf life and sterility of reconstituted drug solutions. Results: Degradation of both Clavulanic acid and Amoxicillin was found to enhance with increasing of storage temperature whereas only the degradation of Clavulanic acid appeared to be affected by storage light conditions. Time dependent changes in colour and pH were observed in reconstituted solutions under all storage conditions, especially in samples stored at 30˚C in indoor room lighting. Best storage conditions for reconstituted co-amoxiclav injectable solutions was determined as refrigerated at 4-8˚C in dark with associated shelf life of 1 hour. All reconstituted solutions complied with the test for sterility. Conclusions: Reconstituted co-amoxiclav injectable solutions should either be used immediately after reconstitution or within a maximum of 1 hour of reconstitution if stored protected from light at 4-8˚C.

Keywords: Co-amoxiclav, injectable solution, stability, shelf life, sterility.


[Full Text Article]

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 March 2021 Issue has been Published, Kindly check it on http://www.ejpmr.com/home/current_issues

  • EJPMR: MARCH ISSUE PUBLISHED

    MARCH Issue has been successfully launched on 1 March 2021.

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI )